Frontis Pharmaceuticals Private Limited
About Frontis Pharmaceuticals Private Limited
Data last updated:
Frontis Pharmaceuticals Private Limited was a private limited company based in Arrah, Bihar, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the medicinal chemical and botanical products segment of the chemicals sector. It was incorporated on 27 November 2012.
The company was registered with the Registrar of Companies (ROC), Patna, under CIN U51909BR2012PTC019521.
The company had an authorised share capital of ₹5 Lakh and a paid-up capital of ₹3 Lakh. It was led by directors including Harendra and Ajay Kumar Singh.
Its last annual general meeting (AGM) was held on 30 September 2015, and its latest financial statements are for the year ended 31 March 2015. The registered office was at C/O Vishnu Dev Prasad Moh – Krishna Bihar Nagar Gothahula Road Ara Bahiro Lak No. 11, Arrah, Bihar, India – 802301.
Company details
Contact details
Frontis Pharmaceuticals Private Limited's registered office is in Arrah, Bihar.
- Registered AddressC/O Vishnu Dev Prasad Moh – Krishna Bihar Nagar Gothahula Road Ara Bahiro Lak No. 11, Arrah, Bihar, India – 802301
- IndustryChemicals, Medicinal Chemical & Botanical Products, Pharmaceuticals, Chemical Products
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Frontis Pharmaceuticals Private Limited
FY 2015 filings availableFinancial Statement Summary
| Metrics | FY 2014-15 |
|---|---|
| Profit and Loss Statement | |
| Revenue from Operations | |
| Other Income | |
| Total Revenue | |
| Cost of Materials Consumed | |
| Employee Benefit Expense | |
| Finance Costs | |
| Depreciation and Amortisation | |
| Other Expenses | |
| Total Expenses | |
| EBITDA | |
| Profit Before Tax | |
| Tax Expense | |
| Net Profit (PAT) | |
| Balance Sheet | |
| Share Capital | |
| Reserves and Surplus | |
| Net Worth (Total Equity) | |
| Long-term Borrowings | |
| Short-term Borrowings | |
| Trade Payables | |
| Total Liabilities | |
| Fixed Assets | |
| Investments | |
| Inventories | |
| Trade Receivables | |
| Cash and Bank Balance | |
| Total Assets | |
Financial Ratios
| Metrics | FY 2014-15 |
|---|---|
| Profitability | |
| EBITDA Margin | |
| Net Profit Margin | |
| Return on Equity (ROE) | |
| Return on Capital Employed (ROCE) | |
| Return on Assets (ROA) | |
| Liquidity and Debt | |
| Current Ratio | |
| Quick Ratio | |
| Debt-to-Equity Ratio | |
| Interest Coverage Ratio | |
| Efficiency and Growth | |
| Asset Turnover | |
| Receivable Days | |
| Payable Days | |
| Inventory Days | |
| Revenue Growth | |
| Net Profit Growth | |
To see the full financial statements and ratios of Frontis Pharmaceuticals Private Limited, buy the company report.
Board of directors of Frontis Pharmaceuticals Private Limited
Frontis Pharmaceuticals has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Harendra | Director | 10 Nov 2015 | 10 Years 11 Months | As last reported |
| Ajay Kumar Singh | Director | 27 Nov 2012 | 13 Years 11 Months | As last reported |
| Santosh Kumar Upadhyay | Director | 27 Nov 2012 | 13 Years 11 Months | As last reported |
Legal cases
No court or tribunal cases involving Frontis Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Frontis Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Frontis Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Frontis Pharmaceuticals Private Limited has 4 board changes on record since 2012: 3 appointments and 1 cessation. The latest: Santosh Kumar Upadhyay ceased to be Director on 13 Jun 2017.
Frequently asked questions
Frontis Pharmaceuticals has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
Frontis Pharmaceuticals was a private limited company based in Arrah, Bihar, India. The company worked in medicinal chemical and botanical products, within the chemicals industry. It was incorporated on 27 November 2012 and is registered under CIN U51909BR2012PTC019521. The company has been struck off by the Registrar of Companies and is no longer operational.
Frontis Pharmaceuticals had 3 directors:
- Harendra - Director
- Ajay Kumar Singh - Director
- Santosh Kumar Upadhyay - Director
The CIN (Corporate Identification Number) of Frontis Pharmaceuticals is U51909BR2012PTC019521. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Frontis Pharmaceuticals is at CO Vishnu Dev Prasad Moh – Krishna Bihar Nagar Gothahula Road Ara Bahiro Lak No. 11, Arrah, Bihar, India – 802301.
Frontis Pharmaceuticals was incorporated on 27 November 2012. It is registered with the Registrar of Companies, Patna.
The latest financial statements of Frontis Pharmaceuticals on record with the MCA are for the year ended 31 March 2015. Its last annual general meeting was held on 30 September 2015. Year-wise statements from 2015 are in the company report.
Frontis Pharmaceuticals operated in the chemicals industry, in the medicinal chemical and botanical products segment. It worked in this industry before it was struck off.
Santosh Kumar Upadhyay ceased to be Director on 13 Jun 2017. Harendra was appointed as Director on 10 Nov 2015. Ajay Kumar Singh was appointed as Director on 27 Nov 2012. Frontis Pharmaceuticals has 4 board changes on record in total.
The compliance status of Frontis Pharmaceuticals is active non-compliant as of 09 September 2026.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
